Differences in Cerebellar Volume as a Diagnostic and Prognostic Biomarker in Children and Adolescents With Epilepsy of Unknown Etiology

J Child Neurol. 2022 Dec;37(12-14):939-948. doi: 10.1177/08830738221114241. Epub 2022 Sep 15.

Abstract

Introduction and objective: Epilepsy is one of the most common brain diseases during childhood and adolescence. Atrophy in different brain areas is possible during epilepsy. This study aimed to verify whether cerebellar volume differences could be detected by volume analysis using magnetic resonance imaging (MRI) in children with epilepsy.

Method: In this retrospective study, 41 children (3.1-18.8 years) with epilepsy of unknown etiology were included (duration of epilepsy 1.9 ± 3 years). A cranial MRI with a volumetric 3-dimensional, T1-weighted sequence was used for volume analysis. The MRIs of 26 patients with headache (5.3-17.1 years) were analyzed for comparison. A volume analysis of the cerebellum was performed using region-based morphometry. Total cerebellar volume, total white and gray matter volume, and 48 regional lobules (L), separated into white and gray matter, were calculated. Cerebellar volumes are presented in relative ratios as the volume fraction of cerebellar volume to total intracranial volume: CV/TIV.

Results: The ratio of overall white matter volume was significantly lower in the case group (23.93 × 10-3, P = .039). A significantly lower ratio of regional white matter volume was detected in LV right (P = .031) and left (P = .014), in LVIIIB right (P = .011) and left (P = .019), and in LVIIIA left (P = .009).

Conclusion: Our results emphasize that volume analysis of the total cerebellar volume alone is insufficient to characterize cerebellar differences in children with epilepsy. Rather, in specific cerebellar region volume analysis using region-based morphometry, children with epilepsy showed significantly lower regional volumes of lobules, which are important for sensorimotor function (LV, LVIII) and higher cognitive function (crus I).

Keywords: Antiepileptic drug; brain; cerebellum; cognition; epilepsy; magnetic resonance imaging; neurodevelopment; pediatric; seizures.

MeSH terms

  • Adolescent
  • Biomarkers
  • Cerebellum* / diagnostic imaging
  • Cerebellum* / pathology
  • Child
  • Epilepsy* / diagnostic imaging
  • Epilepsy* / pathology
  • Humans
  • Magnetic Resonance Imaging
  • Prognosis
  • Retrospective Studies

Substances

  • Biomarkers